Actikerall is a combination of topical fluorouracil and salicylic acid that is used to treat hyperkeratotic actinic keratosis of the skin.
Actikerall (Fluorouracil and salicylic acid) Uses:
-
Hyperkeratotic actinic keratosis:
- Immunocompetent adults with Grade I or Grade II (slightly perceptible and/or moderately thick) hyperkeratotic actinic keratosis of the face, forehead, and balding scalp are eligible for treatment.
Actikerall dose in Adults
Actikerall dose in the treatment of Hyperkeratotic actinic keratosis:
- Apply topically once a day until the lesions have cleared or for a maximum duration of 12 weeks.
- The drug may be used to treat up to ten lesions at the same time; however, avoid exceeding the total treatment area of 25 cm².
- If the disease affects a larger area of the body, try to treat it at the different periods with the most symptomatic lesions treated first.
- When applying the medicine over skin that is sensitive and thin such as around the eyes and temple, or in patients who develop drug-related adverse events, a less frequent application may be more suitable (thrice a week).
- It may take up to 8 weeks(after treatment discontinuation) for optimal therapeutic response to be seen.
-
Missed doses:
- If the dose is missed, avoid applying an extra dose.
- The treatment may be continued at the regularly scheduled time.
Use in Children:
Not indicated.
Actikerall Pregnancy Risk Category: X
- Pregnant women and women at risk of becoming pregnant are advised to not use this medication.
Use of fluorouracil or salicylic acid during breastfeeding
- Breastfeeding women should not use this product.
Dose in Kidney Disease:
Use is contraindicated.
Dose in Liver disease:
No dosage adjustment is necessary.
Common Side Effects of Actikerall (Fluorouracil and salicylic acid):
-
Local:
- Application-Site Pruritus
- Application Site Pain
- Application Site Irritation
- Local Inflammation
- Application Site Erythema
Less Common Side Effects of Actikerall (Fluorouracil and salicylic acid):
-
Dermatologic:
- Crusted skin
- Desquamation
-
Local:
- Skin erosion
Contraindications to Actikerall (Fluorouracil and salicylic acid):
- Allergy reactions to fluorouracil or capecitabine, salicylic acids or other salicylates or any component of this formulation
- Use in the eyes and mucous membranes
- Pregnant or potentially pregnant women
- Women who are lactating
- Patients with severe renal impairment
- Use with dihydropyrimidine (DPD), enzyme inhibitors in conjunction
- Patients with a DPD deficiency.
Warnings and precautions
-
Local skin reactions
- Localized skin reactions may occur in patients with itching, inflammation, redness or burning.
- Patients usually experience mild to moderate skin reactions. However, patients may develop ulcerated lesions or thin epidermis, which can lead to increased incidences of toxic effects.
- Avoid applying to bleeding lesions.
- The local adverse effects of drugs that can cause skin peeling, irritation, desquamation, and irritation may be increased if they are used in combination.
-
Photosensitivity
- Photosensitivity may be caused by the drug. It is important to avoid prolonged exposure to ultraviolet radiation or sunlight during treatment.
-
Dihydropyrimidine dehydrogenase enzyme deficiency:
- People who lack the enzyme activity of dihydropyrimidine deshydrogenase (DPD) may experience severe drug-related toxicities when they use topical fluorouracil.
- Patients can experience nausea, vomiting and stomatitis.
- If there is suspicion of toxicity, it should be stopped immediately. The area should be washed with warm soapy water.
- Patients with a known DPD deficiency are not advised to use it.
Fluorouracil and salicylic acid (topical): Drug Interaction
Risk Factor C (Monitor therapy) |
|
Fosphenytoin |
The serum levels of fosphenytoin may increase when fluorouracil (Topical) is used. |
Gemcitabine |
Fluorouracil serum concentration might rise (Topical). |
Leucovorin Calcium-Levoleucovorin |
may intensify the negative or harmful effects of fluorouracil (Topical). |
Phenytoin |
The serum concentration of phenytoin may rise when fluorouracil (Topical) is administered. |
Vitamin K Antagonists (eg, warfarin) |
The serum concentration of Vitamin K antagonists may rise in response to fluorouracil (Topical). |
Monitoring Parameters:
None mentioned.
How to administer Actikerall (Fluorouracil and salicylic acid)?
- It is intended for topical use only.
- Administration into the eyes, nasal cavity, intravaginal, ears, oral cavity, or inside the anal canal should be avoided.
- The solution may be applied over the face, forehead, and/or scalp via the brush applicator that is connected to the cap.
- Avoid the use of the excessive application by wiping the brush with the neck of the bottle before applying the drug.
- To create a protective film over the treated area, the solution should be allowed to dry.
- The treated area should not be covered after applying the drug.
- Before applying for the medicine, peel off any remaining coating over the area.
- If needed, use warm water to peel off the medicine.
- Avoid contact with healthy skin and over ulcerated lesions or over-bleeding areas of the skin.
Mechanism of action of Fluorouracil and salicylic acid:
Refer to individual agents (fluorouracil, Salicylic acid).
Initial:
- Although treatment can be seen as soon as six weeks after the treatment is completed, full healing may take up to 8 weeks.
Absorption:
- Fluorouracil is minimally absorbed through intact skin (0.035%).
- Contact individual agents.
International Brand Names of Fluorouracil and salicylic acid:
- Actikerall
- Verrucare
- Verruma Hermal
- Verrumal
Fluorouracil and salicylic acid Brand Names in Pakistan:
No Brands Available in Pakistan.